Only one study found that decrease in plasma ApoE was associated with an increase in CSF tau or p‐tau, indicating that a low plasma ApoE levels were unfavorably linked to AD pathology [54] (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.